Nathan Fielder’s Documentary ‘You Can See Everything’ Targets Oscars Best Picture
A24’s documentary “You Can See Everything” chronicles Theranos founder Elizabeth Holmes’s final 34 days before prison.
In Brief
- •A24’s documentary “You Can See Everything” chronicles Theranos founder Elizabeth Holmes’s final 34 days before prison.
- •The film premiered with a secret screening at the Telluride Film Festival and later screened at the New York Film Festival.
- •Director Nathan Fielder and co‑director Lance Oppenheim aim to position the documentary for the Academy’s Best Picture category.
- •The film’s release follows a surge of interest in Theranos’s story and the broader scrutiny of biotech fraud.
Why It Matters
The documentary offers a rare, intimate look at the rise and fall of Theranos, a company that once promised to revolutionize medical testing but ultimately collapsed under fraud allegations. By targeting the Academy’s Best Picture category, the film seeks to elevate the conversation around corporate accountability and the ethical responsibilities of biotech innovators, potentially reshaping public perception and influencing future regulatory scrutiny.
Key Details
- Director
- Nathan Fielder
- Co‑director
- Lance Oppenheim
- Production Company
- A24
- Subject
- Elizabeth Holmes
- Screening Locations
- Telluride Film Festival, New York Film Festival
- Target Award
- Academy Award for Best Picture
Context & Background
Theranos, a once‑promising biotech startup, collapsed after revelations that its blood‑testing technology was fraudulent, leading to Elizabeth Holmes’s criminal trial and imprisonment.
Original Reporting & Sources
VNews is an independent briefing product. Original reporting remains credited to the following publishers:
This brief was synthesized automatically using attributed third-party reporting. VNews is a digital news publication produced under the VContent Group brand and operated by Francis Vincent Sunday in Ghana, independent from the publishers cited above. Read our AI Transparency Policy and Editorial & Corrections Policy.